DXA for Bone Mineral Density Testing: A Safety Measure For Your Clinical Trial


In this video, hear from Jon Riek, PhD, Vice President, Musculoskeletal & Metabolic Imaging, Philips Pharma Solutions, about DXA (dual-energy X-ray absorptiometry) for bone mineral density testing.

DXA remains the gold standard test for bone mineral density assessments. In clinical trials, outside of bone-related conditions and treatments, DXA scans can be used to ensure that a treatment is not having an unintended impact on bone integrity. Could their use become more widespread in clinical trials, akin to cardiac safety testing?

Hear more about how DXA scans work, who should get one and their use in trials.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader